NWU22-12-01 A PHASE 2 PLACEBO-CONTROLLED TRIAL OF UROLITHIN A SUPPLEMENTATION IN MEN WITH PROSTATE CANCER UNDERGOING RADICAL PROSTATECTOMY
Clinical Trial Grant
Administered By
Urology
Awarded By
Northwestern University
Start Date
July 1, 2024
End Date
July 31, 2025
Administered By
Urology
Awarded By
Northwestern University
Start Date
July 1, 2024
End Date
July 31, 2025